Parecer de pré-exame
#6.23
07/09/2024
RPI 2792
Application data
Number
112019014707Type
Filing
Publication
PCT
US2018014532 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 07/09/2024. We update with every new RPI gazette, published weekly.
Applicants
CORVIDIA THERAPEUTICS, INC.
US
NOVO NORDISK A/S
DK
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES
US
Inventors
A. R. (pessoa física)
US
A. W. (pessoa física)
US
C. L. (pessoa física)
US
D. S. (pessoa física)
US
M. D. (pessoa física)
US
S. G. (pessoa física)
US
IPC Classification
Priority claims
US
62/448,358 · 01/19/2017
US
62/476,531 · 03/24/2017
US
62/476,535 · 03/24/2017
Abstract
A divulgação provê peptídeos miméticos de apolipoproteína C-II (apoC-II) e métodos para tratar hipertrigliceridemia em um paciente com uma quantidade eficaz de um peptídeo mimético de apoC-II.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
07/09/2024
RPI 2792
#25.7
05/17/2022
RPI 2680
#25.1
01/18/2022
RPI 2663
#15.35
10/19/2021
RPI 2650
#1.3
04/07/2020
RPI 2570
#1.1
07/30/2019
RPI 2534
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.